These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 32521474)

  • 1. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective Cognitive Decline Modifies the Relationship Between Cerebral Blood Flow and Memory Function in Cognitively Normal Older Adults.
    Hays CC; Zlatar ZZ; Campbell L; Meloy MJ; Wierenga CE
    J Int Neuropsychol Soc; 2018 Mar; 24(3):213-223. PubMed ID: 28974274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging.
    Schuff N; Matsumoto S; Kmiecik J; Studholme C; Du A; Ezekiel F; Miller BL; Kramer JH; Jagust WJ; Chui HC; Weiner MW
    Alzheimers Dement; 2009 Nov; 5(6):454-62. PubMed ID: 19896584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.
    Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction.
    Cui Y; Liang X; Gu H; Hu Y; Zhao Z; Yang XY; Qian C; Yang Y; Teng GJ
    Brain Imaging Behav; 2017 Oct; 11(5):1248-1257. PubMed ID: 27714551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
    Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
    Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes.
    Bangen KJ; Werhane ML; Weigand AJ; Edmonds EC; Delano-Wood L; Thomas KR; Nation DA; Evangelista ND; Clark AL; Liu TT; Bondi MW
    Front Aging Neurosci; 2018; 10():270. PubMed ID: 30250430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.
    Schreiber SJ; Doepp F; Spruth E; Kopp UA; Valdueza JM
    J Neurol; 2005 Oct; 252(10):1171-7. PubMed ID: 16151603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia.
    Gyanwali B; Tan CS; Petr J; Escobosa LLT; Vrooman H; Chen C; Mutsaerts HJ; Hilal S
    AJNR Am J Neuroradiol; 2022 Oct; 43(10):1418-1423. PubMed ID: 36562454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
    Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R
    J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.
    Xie L; Dolui S; Das SR; Stockbower GE; Daffner M; Rao H; Yushkevich PA; Detre JA; Wolk DA
    Neuroimage Clin; 2016; 11():388-397. PubMed ID: 27222794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.
    Duan W; Sehrawat P; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2020; 76(3):1103-1120. PubMed ID: 32597803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes.
    Brundel M; van den Berg E; Reijmer YD; de Bresser J; Kappelle LJ; Biessels GJ;
    J Diabetes Complications; 2012; 26(3):205-9. PubMed ID: 22520398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.
    Benedictus MR; Binnewijzend MAA; Kuijer JPA; Steenwijk MD; Versteeg A; Vrenken H; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Neurobiol Aging; 2014 Dec; 35(12):2665-2670. PubMed ID: 25018106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative transport mapping of multi-delay arterial spin labeling MRI detects early blood perfusion alterations in Alzheimer's disease.
    Guo Y; Zhou L; Li Y; Chiang GC; Liu T; Chen H; Huang W; de Leon MJ; Wang Y; Chen F
    Alzheimers Res Ther; 2024 Jul; 16(1):156. PubMed ID: 38978146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.